by DivRank | Apr 30, 2025 | Downgrades
Goldman Sachs has recently downgraded Starbucks Corporation (NASDAQ: SBUX) from “Buy” to “Neutral,” adjusting its price target to $85. The downgrade reflects mounting concerns about the company’s weakening growth trajectory and a valuation that...
by DivRank | Apr 30, 2025 | Downgrades
Wells Fargo recently shifted its rating on Gap Inc. (NYSE: GPS) from “Overweight” to “Equal Weight” with a revised price target of $24. The move signals growing concern over the company’s ability to maintain momentum amid brand inconsistencies...
by DivRank | Apr 29, 2025 | Downgrades
ConocoPhillips (NYSE: COP) has been downgraded by BofA Securities from Buy to Neutral. The move reflects growing caution around the short-term outlook for crude oil prices, which could weigh heavily on the company’s earnings growth. Despite strong operational...
by DivRank | Apr 29, 2025 | Downgrades
UBS has shifted its rating on National Grid (NYSE: NGG) from Buy to Neutral, signaling a cooling of optimism around the company’s near-term growth potential. National Grid has long been a staple for conservative, income-seeking investors, but UBS analysts cited...
by DivRank | Apr 28, 2025 | Downgrades
Eli Lilly (NYSE: LLY) has long been the darling of the pharmaceutical sector, riding the high of groundbreaking treatments and blockbuster sales. However, HSBC Securities recently turned heads by downgrading the stock from Buy to Reduce, slashing their price target...
by DivRank | Apr 28, 2025 | Downgrades
Eastman Chemical Co. (NYSE: EMN) faced a notable downgrade this week as JP Morgan shifted its rating from Overweight to Neutral, adjusting its price target to $76. The move signals a cooling sentiment around Eastman’s near-term prospects after months of sluggish...
